Peptide and oligonucleotide cdmo market to reach $4.03 billion by 2030 at 10.5% cagr, driven by growing adoption of personalized medicine.
Read More
Peptide and anticoagulant drugs market to reach $2.47 billion by 2030 at 9.9% cagr, driven by rising prevalence of chronic diseases.
Read More
The global pentavalent market to reach $3.39 billion by 2030 at 4.7% cagr, driven by rising prevalence of diphtheria.
Read More
Pegfilgrastim biosimilars market to reach $2.65 billion by 2030 at 6.7% cagr, driven by increased incidence of cancer.
Read More
Pediatric vaccine market to reach $107.8 billion by 2030 at 13.5% cagr, driven by rising prevalence of pediatric diseases.
Read More
Pediatric supplements market to reach $5.76 billion by 2030 at 6.5% cagr, driven by growing prevalence of nutritional deficiencies.
Read More
The global pediatric drugs market to reach $352.69 billion by 2030 at 14.4% cagr, driven by growing number of preterm births.
Read More
Pediatric asthma treatment market to reach $15.14 billion by 2030 at 5.3% cagr, driven by increasing prevalence of respiratory infections.
Read More
Peanut allergy treatment market to reach $0.8 billion by 2030 at 9.7% cagr, driven by investment in research and development of allergy treatments.
Read More
Pd-1 and pdl1 inhibitors immune checkpoint inhibitors market to reach $103.27 billion by 2030 at 14.6% cagr, driven by rising prevalence of cancer cases.
Read More